November 28th 2024
Researchers at the University of Colorado Anschutz Medical Campus found that characters with crossed or drifting eyes are more likely to play more minor roles in animated movies and be considered unintelligent or villainous. These depictions, the researchers say, can have harmful effects for children with strabismus by perpetuating stereotypes.
November 28th 2024
November 23rd 2024
November 14th 2024
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
EnVision Summit
February 14-17, 2025
Register Now!
Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments
March 16, 2025
Register Now!
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Refractive surgery an option for kids with high bilateral myopia
October 15th 2005Orlando—Refractive surgery may be an option for treating children with high myopia and neurobehavioral disorders who are unable to use either of the two principal methods of correcting myopia, spectacles or contact lenses.
Read More
Refractec promotes Frinzi to chief operating officer
October 14th 2005Refractec Inc. announces the promotion of Thomas G. Frinzi to the newly created position of chief operating officer to oversee the company?s growing global operations. Frinzi, formerly senior vice president of sales and marketing, will add clinical, regulatory affairs, and quality assurance to his sales and marketing responsibilities. He continues to report directly to President and CEO Mitchell B. Campbell.
Read More
Dry eye a constantly changing landscape
September 1st 2005Washington, DC-Dry eye disease affects millions of people worldwide and with that has come a recent greater awareness among patients that it is indeed a problem. As the recognition of the magnitude of dry eye is changing, so too has knowledge of its pathogenesis, the technology facilitating diagnosis, and the drugs that are becoming available to treat it. General ophthalmologists will be increasingly challenged to learn more about the disease and the best ways to treat individual patients, according to Michael Lemp, MD.
Read More
High-frequency UBM helpful tool in strabismus reoperation
September 1st 2005Orlando—The high-frequency ultrasound biomicroscope (UBM) can reliably estimate the distance of horizontal muscle insertion from the limbus in eyes that had previous strabismus surgery on the same muscle, according to Shuan H. Dai, MB, BS, FRANZCO, a pediatric ophthalmologist.
Read More
AAPOS backs pediatric screening
July 15th 2005Orlando—Ongoing efforts to encourage the adoption of mandatory preschool vision screening in every state were the main topic of discussion during a workshop at the annual meeting of the American Academy of Pediatric Ophthalmology and Strabismus (AAPOS).
Read More
Pediatric eye specialist honored at meeting
May 15th 2005Orlando—The American Association for Pediatric Ophthalmology and Strabismus recently honored Leonard Apt, MD, professor of ophthalmology and founding director of the division of pediatric ophthalmology at the Jules Stein Eye Institute at UCLA, at the group's annual meeting here.
Read More
Atropine treatment of moderate amblyopia assessed
April 1st 2005Baltimore—Prescribed weekend atropine sulfate 1% appears to be as effective as prescribed daily use for treating moderate amblyopia in young children, according to results from a study conducted by the Pediatric Eye Disease Investigator Group.
Read More
Transitions offers initiatives for success
March 15th 2005Orlando—Transitions Optical is offering new point-of-sale tools that allow eye-care professionals to add a personal touch to their discussion of healthy vision with patients. More than half of the materials now offered are customizable using the Transitions Online Marketing (TOM) tool.
Read More
J&J increases Definity lenses distribution
March 15th 2005Atlanta—Robertson Optical Laboratories, which operates wholesale lab branches in Georgia and South Carolina, has been selected as one of two wholesale lab companies to be authorized distributors of Definity lenses by manufacturer Johnson & Johnson.
Read More
TTT stabilizes vision in advanced AMD-related CNV
March 15th 2005Coronado, CA—Transpupillary thermotherapy (TTT) alone and combined with a single pretreatment intravitreal injection of triamcinolone acetonide 4 mg are similarly associated with vision stabilization over a 6-month follow-up period in eyes with large complicated choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), reported Jans Fromow-Guerra, MD, PhD, at the annual meeting of the American Society of Retinal Specialists.
Read More
Corticosteroids may benefit pediatric orbital cellulitis
March 15th 2005Houston—Use of intravenous corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess did not have an adverse effect on clinical outcomes and may be beneficial, according to Michael T. Yen, MD.
Read More
Allergic disease therapies key to patient quality of life
March 1st 2005Quality of life (QOL) has become an issue in every branch of medicine, including ophthalmology. From an economic perspective, loss of productivity contributes to the economic burden of a disease in the same manner as the shared costs of treatment.
Read More